It will be exciting to see future studies that fully elucidate the role of TSS2 in MYB gene activation and expression, the extent of its interaction with hijacked enhancers, and its full functional consequences in ACC tumors. This evidence concerns the gene MYB and adrenal cortex carcinoma.